BW

Oklo Prepares for the Deployment of its Commercial-Scale Fuel Recycling Facility with the Submission of its Licensing Project Plan

Oklo has submitted a licensing project plan to the U.S. Nuclear Regulatory Commission, outlining Oklo's plans for pre-application engagement activities that support the submission of a license application for its commercial-scale fuel recycling facility. The first-of-a-kind fuel recycling facility will produce fuel to support the deployment of Oklo's advanced fission…
Leer más...

Sourcepoint announces launch of solution to pinpoint source of third-party scripts that pose privacy risks for publishers and brands

Vendor Trace flags privacy risks and allows customers to understand how personal data flows through the chain of referral NEW YORK--(BUSINESS WIRE)--#CCPA--Sourcepoint, the data privacy software company for the digital marketing ecosystem, today launches Vendor Trace to provide publishers and brands with an easy way to monitor downstream vendor behavior…
Leer más...

Blackford and Brainomix Announce AI Partnership for Stroke Care

Strategic partnership increases access to advanced AI-assisted stroke care EDINBURGH, Scotland--(BUSINESS WIRE)--#AI--Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech solutions company, have announced a strategic partnership to bring Brainomix’s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more…
Leer más...

United States Complete Video Library Directory 2023: Complete Bibliographic Information on the Thousands of Video Options Available for Public, Community, and Academic Libraries – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Complete Video Directory 2023 Edition" book has been added to ResearchAndMarkets.com's offering. Since 1988, the Complete Video Directory has been the go-to source for complete bibliographic information on the thousands of video options available for public, community, and academic libraries across the nation. Completely updated for 2023, this…
Leer más...

Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced that European Commission has granted orphan drug designation (ODD) for PXL770 and PXL065 for the treatment…
Leer más...

Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers

Following expiration of Hart-Scott-Rodino waiting period regarding expansion of their collaboration on NK cell engagers, the licensing agreement between Sanofi and Innate is now effective. MARSEILLE, France--(BUSINESS WIRE)--#ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced today the expiration of the waiting period under the Hart-Scott-Rodino…
Leer más...

Techstars, MCIT, RAED Ventures and Saudi National Bank Announce the Continuation of The Riyadh Techstars Accelerator

The program is now accepting applications and will help drive more innovation and entrepreneurship in the growing Middle East startup ecosystem BOULDER, Colo.--(BUSINESS WIRE)--Techstars, one of the largest pre-seed investors in the world, in collaboration with the Ministry of Communications and Information Technology of the Kingdom of Saudi Arabia (MCIT),…
Leer más...

Y-MABS THERAPEUTICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. – YMAB

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 20, 2023 to file lead plaintiff applications in a securities class action lawsuit against Y-mAbs Therapeutics, Inc. (NasdaqGS: YMAB), if they purchased the…
Leer más...